Azarm Supplements Canada Inc. was incorporated in British Columbia on August 24, 2021, under corporate number BC1321193. It is located at 4170 Still Creek Drive, Suite 200, Burnaby BC, V5C 6C6.
Azarm Supplements Canada Inc. is a shared capital entity, and has issued 1,000 common shares, out of which, the Parent Company owns 800 shares, and the remaining 200 shares belong to Dr. Abbasi.
The Subsidiary is run and directed by Dr. Abbasi; however, the Parent Company retains the ultimate decision-making and supervision power over the Subsidiary, through its voting power, written arrangements, and financial means.
The Parent Company has identified several strategies for its expansion to the Canadian market. Its main plan is to export the products that are readily available in the Canadian market to the Middle-East, where demand for such products is high. One serious barrier that impedes their plan to import high-end products into Iran and neighbouring countries is the US sanctions. Through a Canadian based organization, the Parent Company shall be able to grow its business and import the high-end products not otherwise available in Iran and the Middle-East markets.
Relying and leveraging its experience, expertise and financial backups, the Parent Company has adopted a resolution on August 16, 2021 mandating Dr. Abbasi to spearhead the Canadian operations. Accordingly, the necessary arrangements have been done and the Subsidiary has been incorporated under the name of “Azarm Supplements Canada Inc.”